A Study of YM178 in Patients With Symptomatic Overactive Bladder (DRAGON)
NCT00337090
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
1108
Enrollment
INDUSTRY
Sponsor class
Conditions
Overactive Bladder
Interventions
DRUG:
YM178
Sponsor
Astellas Pharma Inc
Collaborators
[object Object]